Polish Translation and Validation of the SARC-F Tool for the Assessment of Sarcopenia.
muscle mass
older adults
sarcopenia
screening
Journal
Clinical interventions in aging
ISSN: 1178-1998
Titre abrégé: Clin Interv Aging
Pays: New Zealand
ID NLM: 101273480
Informations de publication
Date de publication:
2020
2020
Historique:
received:
07
01
2020
accepted:
31
03
2020
entrez:
6
5
2020
pubmed:
6
5
2020
medline:
24
9
2020
Statut:
epublish
Résumé
Completion of the SARC-F questionnaire constitutes the obligatory first step in the diagnostic process of sarcopenia, according to the revised European consensus on the definition and diagnosis of sarcopenia published by the European Working Group on Sarcopenia in Older People2 (EWGSOP2). SARC-F has been recognized as the most up-to-date and coherent screening tool for sarcopenia. The aim of the study was to translate and to validate the Polish version of the SARC-F questionnaire. The validation process was performed in two stages: 1) translation and intercultural adaptation and 2) clinical validation. The inclusion criteria were as follows: age ≥65 years, unimpaired mobility, and no cognitive impairment. The EWGSOP2 criteria were used to diagnose sarcopenia. Hand grip strength measurement, physical fitness test, and body weight composition analysis were conducted. Sensitivity, specificity, accuracy-likelihood ratios, and SARC-F predictive values were calculated using the EWGSOP2 criteria. Sixty-seven people participated in the study of whom 21% were diagnosed with sarcopenia (SARC-F score: ≥4). The reliability of the questionnaire based on the Cronbach's alpha coefficient was 0.784. Sensitivity, specificity, and negative predictive values were 92.9%, 98.1%, and 98.1%, respectively. The process of validating the SARC-F questionnaire against Polish conditions demonstrated its applicability as a simple and reliable tool for diagnosing sarcopenia in daily clinical practice with older adults.
Identifiants
pubmed: 32368023
doi: 10.2147/CIA.S245074
pii: 245074
pmc: PMC7185989
doi:
Types de publication
Journal Article
Validation Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
567-574Commentaires et corrections
Type : CommentIn
Type : CommentIn
Informations de copyright
© 2020 Zasadzka et al.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest in this work.
Références
Geriatr Gerontol Int. 2019 Nov;19(11):1172-1178
pubmed: 31535433
J Cachexia Sarcopenia Muscle. 2016 Mar;7(1):28-36
pubmed: 27066316
J Am Med Dir Assoc. 2015 Mar;16(3):247-52
pubmed: 25548028
Gerontologist. 1969 Autumn;9(3):179-86
pubmed: 5349366
Int J Geriatr Psychiatry. 2000 Nov;15(11):1021-7
pubmed: 11113982
Age Ageing. 2019 Jan 1;48(1):16-31
pubmed: 30312372
Age Ageing. 2010 Jul;39(4):412-23
pubmed: 20392703
Ann Intern Med. 1995 Nov 1;123(9):727-8
pubmed: 7574231
Health Care Women Int. 2011 Dec;32(12):1031-45
pubmed: 22087593
Geriatr Gerontol Int. 2014 Feb;14 Suppl 1:93-101
pubmed: 24450566
J Cachexia Sarcopenia Muscle. 2016 Jun;7(3):290-8
pubmed: 27239410
J Am Med Dir Assoc. 2016 Dec 1;17(12):1142-1146
pubmed: 27815111
J Frailty Aging. 2018;7(1):2-9
pubmed: 29412436
Int J Environ Res Public Health. 2017 Jul 19;14(7):
pubmed: 28753945
J Am Med Dir Assoc. 2016 Dec 1;17(12):1136-1141
pubmed: 27650212
J Nutr Health Aging. 2014 Mar;18(3):277-83
pubmed: 24626755
Gerontologist. 1970 Spring;10(1):20-30
pubmed: 5420677
J Nutr Health Aging. 2019;23(6):518-524
pubmed: 31233072
J Psychiatr Res. 1982-1983;17(1):37-49
pubmed: 7183759
Nutrition. 1999 Feb;15(2):116-22
pubmed: 9990575
J Am Med Dir Assoc. 2013 Aug;14(8):531-2
pubmed: 23810110
J Am Med Dir Assoc. 2014 Sep;15(9):630-4
pubmed: 24947762
J Am Med Dir Assoc. 2018 Jan;19(1):40-45.e1
pubmed: 28843526
BMC Geriatr. 2016 Oct 5;16(1):170
pubmed: 27716195
Arch Gerontol Geriatr. 2014 Sep-Oct;59(2):295-9
pubmed: 24852668
N Engl J Med. 1995 Mar 2;332(9):556-61
pubmed: 7838189